"Widening of Char Dham Yatra routes have made pilgrimage more accessible, safe": Uttarakhand CM Dhami

Rishikesh, April 20 -- Uttarakhand Chief Minister Pushkar Singh Dhami on Monday said that under the guidance of Prime Minister Narendra Modi, the widening and strengthening of routes have made Char Dh... Read More

What Foods are High in Vitamin K? Know Natural Sources, Benefits, Symptoms of Low Vitamin K, How to Recover, Who Needs to Avoid & More

India, April 20 -- Among the other Vitamins, Vitamin K is also essential for your body. It helps in maintaining your bone health, cardiovascular health, and supports blood clotting. It acts as a coenz... Read More

From Panchayats to Parliament: The Road to Women's Reservation

Jammu, April 20 -- The Nari Shakti Vandan Adhiniyam, 2023, commonly called the Women's Reservation Bill or Nari Shakti Bill, is the Constitution (One Hundred and Sixth Amendment) Act that reserves one... Read More

Another Tragedy

Jammu, April 20 -- Yet another road accident in Udhampur District that left 21 commuters dead and 51 others injured sent entire region into the mourning and once again brought to fore that over speedi... Read More

Baramulla ramps up preparations for Census 2027

BARAMULLA, April 20 -- Chief Planning Officer (CPO) Baramulla, Nisar Ahmad today chaired a review meeting of charge officers at the DC office meeting hall here to assess the preparedness for the upcom... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More

• ««
• «
• 4291
• 4292
• 4293
• 4294
• 4295
• 4296
• 4297
• 4298
• 4299
• 4300
• »
• »»